Skip to content

Author

R. Graham

We have 4 of 51 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Trichrome-based deep learning for quantitative assessment of steatosis, hepatocellular ballooning, and fibrosis in metabolic dysfunction-associated steatohepatitis.

AIMS This study aimed to develop and evaluate Tri-MASH, a trichrome-based deep learning model for quantitative assessment of steatosis, classic hepatocellular ballooning, and fibrosis, and to explore their spatial relationships. Inflammatory-cell density was evaluated as an exploratory measure. METHODS AND RESULTS Tr...

B. U. Park, B. Hassan, Saadiya Nazli et al. · 0 citations
Open access Oct 2026

Tumor Cell-Free DNA Assay Analytical Performance in 101 Clinical Laboratories Participating in a College of American Pathologists Proficiency Testing Program

Tumor cell-free DNA (cfDNA) assays are increasingly used for mutation detection in therapy selection and disease monitoring. This study evaluates the laboratory performance in College of American Pathologists (CAP) Molecular Oncology Committee tumor cfDNA proficiency testing (PT) during a 2-year period. To a...

Christina M. Lockwood, Venkata Yellapantula, Jonathan Tsai et al. · 0 citations
Open access Aug 2026

Phase 2 study of futibatinib in combination with pembrolizumab in patients with FGF19 expressing advanced hepatocellular carcinoma

Futibatinib plus pembrolizumab demonstrated an acceptable safety profile but did not meet efficacy thresholds supporting further study in FGF19-expressing HCC, an unmet need after first-line immunotherapy.

Nguyen H. Tran, M. Palmer, Angela Ulrich et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.